|
Market Closed -
Nasdaq
04:00:00 2026-08-26 pm EDT
|
5-day change | 1st Jan Change | ||
| 148.09 USD | -0.46% |
|
+0.33% | +20.65% |
| Aug. 25 | Wall Street Wants Receipts |  |
| Aug. 25 | Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 150.03 | 150.03 | 154.98 |
| Spread/Res. | -1.29% | -1.29% | -4.45% |
| Spread/Supp. | +6.69% | +21.90% | +32.11% |
| Support | 138.8 | 121.48 | 112.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
